Endothelin-1 Stimulates PAI-1 Protein Expression via Dual Transactivation Pathway Dependent ROCK and Phosphorylation of Smad2L

Endothelin-1 Stimulates PAI-1 Protein Expression via Dual Transactivation Pathway Dependent ROCK and Phosphorylation of Smad2L

Objective: In addition to the carboxy region, Smad2 transcription factor can be phosphorylated in the linker region aswell. Phosphorylation of Smad2 linker region (Smad2L) promotes the expression of plasminogen activator inhibitor type1 (PAI-1) which leads to cardiovascular disorders such as atheros...

Full description

Bibliographic Details
Main Authors:	hossein babaahmadi rezaei, alireza kheirolah, Faezeh Seif
Format:	Article
Language:	English
Published:	Royan Institute (ACECR), Tehran 2022-08-01
Series:	Cell Journal
Subjects:	atherosclerosis rock smad2 transactivation
Online Access:	https://www.celljournal.org/article_253330_c2d6823710743cbe2c230eabdb8a619a.pdf

Similar Items

Transactivation of Human Endogenous Retroviruses by Viruses
by: Erin F. Evans, et al.
Published: (2024-10-01)

Xbra modulates the activity of linker region phosphorylated Smad1 during Xenopus development
by: Santosh Kumar, et al.
Published: (2024-04-01)

Sp1 facilitates continued HSV-1 gene expression in the absence of key viral transactivators
by: Catherine N. Sodroski, et al.
Published: (2024-03-01)

Mechanisms involved in PGE<sub>2</sub>-induced transactivation of the epidermal growth factor receptor in MH<sub>1</sub>C<sub>1</sub> hepatocarcinoma cells
by: Tveteraas Ingun, et al.
Published: (2012-09-01)

Myostatin Increases Smad2 Phosphorylation and Atrogin-1 Expression in Chick Embryonic Myotubes
by: Takaoki Saneyasu, et al.
Published: (2019-07-01)

Transactivation of the EGF receptor as a novel desensitization mechanism for G protein-coupled receptors, illustrated by dopamine D2-like and β2 adrenergic receptors
by: Dooti Kundu, et al.
Published: (2024-10-01)

Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy
by: Christian L Althaus, et al.
Published: (2010-02-01)

Atorvastatin’s Therapeutic Potential in Atherosclerosis: Inhibiting TGF-β-Induced Proteoglycan Glycosaminoglycan Chain Elongation through ROS-ERK1/2-Smad2L Signaling Pathway Modulation in Vascular Smooth Muscle Cells
by: Hossein Ghaderi-Zefrehi, et al.
Published: (2024-02-01)

HpFBH3 transactivates HpCO7 via binding to the E-boxes in the promoter and may accelerate flower formation in pitaya
by: Xiaowei Cai, et al.
Published: (2025-02-01)

Multivalent and Bidirectional Binding of Transcriptional Transactivation Domains to the MED25 Coactivator
by: Heather M. Jeffery, et al.
Published: (2020-08-01)

SMAD3 rs17228212 Polymorphism Is Associated with Advanced Carotid Atherosclerosis in a Slovenian Population
by: David Petrovič, et al.
Published: (2024-05-01)

NRF2 Activation in Autophagy Defects Suppresses a Pharmacological Transactivation of the Nuclear Receptor FXR
by: Eun Young Kim, et al.
Published: (2022-02-01)

Basal Autophagy Is Necessary for A Pharmacologic PPARα Transactivation
by: Eun Young Kim, et al.
Published: (2022-02-01)

Arl15 upregulates the TGFβ family signaling by promoting the assembly of the Smad-complex
by: Shi, Meng, et al.
Published: (2022)

High Glucose Increases Lactate and Induces the Transforming Growth Factor Beta-Smad 1/5 Atherogenic Pathway in Primary Human Macrophages
by: Kareem Awad, et al.
Published: (2024-07-01)

Anti-Inflammatory Effect of Resveratrol Derivatives via the Downregulation of Oxidative-Stress-Dependent and c-Src Transactivation EGFR Pathways on Rat Mesangial Cells
by: I-Ta Lee, et al.
Published: (2022-04-01)

Correspondence on editorial regarding “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
by: Mehrangiz Dezhbord, et al.
Published: (2024-10-01)

A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival
by: Singh Puneet, et al.
Published: (2011-12-01)

Non-Immune-Mediated, p27-Associated, Growth Inhibition of Glioblastoma by Class-II-Transactivator (CIITA)
by: A Katherine Tan, et al.
Published: (2024-11-01)

High‐throughput discovery of functional disordered regions: investigation of transactivation domains
by: Charles NJ Ravarani, et al.
Published: (2018-05-01)

Graded or threshold response of the tet-controlled gene expression: all depends on the concentration of the transactivator
by: Heinz Niels, et al.
Published: (2013-01-01)

Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
by: T Mahdloo, et al.
Published: (2023-04-01)

High-Level Production of scFv-Fc Antibody Using an Artificial Promoter System with Transcriptional Positive Feedback Loop of Transactivator in CHO Cells
by: Binbin Ying, et al.
Published: (2023-11-01)

Activation of CD137 Signaling Promotes Angiogenesis in Atherosclerosis via Modulating Endothelial Smad1/5‐NFATc1 Pathway
by: Jiayi Weng, et al.
Published: (2017-03-01)

Smad1 Expression in Follicular Lymphoma
by: Jai Hyang Go
Published: (2015-05-01)

The ETV6-MECOM fusion protein promotes EMT-related properties by repressing the transactivation activity of E-cadherin promoter in K562 leukemia cells
by: Qian Li, et al.
Published: (2024-07-01)

Case report: A de novo Non-sense SOX9 mutation (p.Q417*) located in transactivation domain is Responsible for Campomelic Dysplasia
by: Xingxing Qiao, et al.
Published: (2023-01-01)

HIV-1 Tat amino acid residues that influence Tat-TAR binding affinity: a scoping review
by: Piwai Terry Gotora, et al.
Published: (2023-03-01)

The role of green peas protein hydrolysate in TGF/SMAD signaling to prevent renal fibrosis
by: Meilinah Hidayat, et al.
Published: (2022-06-01)

Synthesis and biological evaluation of dihydropyrano-[2,3-c]pyrazoles as a new class of PPARγ partial agonists
by: Qvortrup, Katrine, et al.
Published: (2017)

Epigallocatechin-3-Gallate Suppresses BMP-6-Mediated SMAD1/5/8 Transactivation of Hepcidin Gene by Inducing SMILE in Hepatocytes
by: Yu-Ji Kim, et al.
Published: (2021-10-01)

TGF‐β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways
by: Yuanyuan Zhao, et al.
Published: (2018-03-01)

Differential Smad2/3 linker phosphorylation is a crosstalk mechanism of Rho/ROCK and canonical TGF-β3 signaling in tenogenic differentiation
by: Michaela Melzer, et al.
Published: (2024-05-01)

Nicorandil mitigates arthrogenic contracture induced by knee joint extension immobilization in rats: interference with RhoA/ROCK signaling and TGF-β1/Smad pathway
by: XM Li, et al.
Published: (2024-03-01)

TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity
by: Arjan van Caam, et al.
Published: (2017-05-01)

Visualization of the binding between gintonin, a Panax ginseng-derived LPA receptor ligand, and the LPA receptor subtypes and transactivation of the EGF receptor
by: Sun-Hye Choi, et al.
Published: (2022-05-01)

USF1 transcriptionally activates USP14 to drive atherosclerosis by promoting EndMT through NLRC5/Smad2/3 axis
by: Zhiwen Zhang, et al.
Published: (2024-02-01)

Baicalin protects against renal interstitial fibrosis in mice by inhibiting the TGF-β/Smad signalling pathway
by: Hui Wang, et al.
Published: (2022-12-01)

Structural Basis for the Interaction between p53 Transactivation Domain and the Mediator Subunit MED25
by: Min-Sung Lee, et al.
Published: (2018-10-01)

Role of TGF-β1/SMAD signaling cascade in the regulation of cyclooxygenase-2 expression in human breast cancer cells
by: M. A. Taipov, et al.
Published: (2014-07-01)